ARID1A and TERT promoter mutations in dedifferentiated meningioma

While WHO grade I meningiomas are considered benign, patients with WHO grade III meningiomas have very high mortality. The principles underlying tumor progression in meningioma are largely unknown yet a detailed understanding of these mechanisms will be required for effective management of patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Genet
Autores principales: Abedalthagafi, Malak S., Bi, Wenya Linda, Merrill, Parker H., Gibson, William J., Rose, Matthew F., Du, Ziming, Francis, Joshua M., Du, Rose, Dunn, Ian F., Ligon, Azra H., Beroukhim, Rameen, Santagata, Sandro
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4882906/
https://ncbi.nlm.nih.gov/pubmed/25963524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cancergen.2015.03.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares